WILLIAM RIEFLIN

Profile

First Name

: WILLIAM

Middle Name

:

Last Name

: RIEFLIN

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER, DIRECTOR

NGM BIOPHARMACEUTICALS INC

LUIS BAYOL, JIN-LONG CHEN, DAVID GOEDDEL, DAVID V. GOEDDEL, HELEN KIM, MARC LESCHLY, MARK LESCHLY, ARTHUR LEVINSON, ARTHUR D. LEVINSON, WILLIAM J. RIEFLIN, DAVID SCHNELL, PETER SVENNILSON, MCHENRY T. TICHENOR, JR.

DIRECTOR

ANACOR PHARMACEUTICALS, INC.

PAUL BERNS, SANJAY CHANDA, IRWIN HEYMAN, ZHI HONG, ANDERS HOVE, PAUL KLINGENSTEIN, MARK LESCHLY, KIRK MAPLES, RICHARD MARKHAM, GEOFFREY PARKER, DAVID PERRY, JACOB PLATTNER, LUCY SHAPIRO, LEE ZANE

DIRECTOR

FLEXUS BIOSCIENCES, INC.

LUIS BAYOL, DAVE GOEDDEL, JUAN CARLOS JAEN, TERRY ROSEN, BETH SEIDENBERG

DIRECTOR

KENNETH CLARK, ADAM GOULBURN, TIM KUTZKEY, TOM MANIATIS, TERRY MCGUIRE, MICHAEL O-DONNELL, NANCY THORNBERRY, JOSHUA WOLFE

DIRECTOR

LYCIA THERAPEUTICS, INC.

TIM ANDERSON, AMY BACHRODT, JEREMY S. CALDWELL, MING FANG, LAURENT FISCHER, ANDREW GOTTESDIENER, CLARE OZAWA, AETNA WUN TROMBLEY, THOMAS WOIWODE

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2026-06-10

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2024-04-26

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-09-02

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2015-09-30

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2013-10-30

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

2013-06-07

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2013-04-05

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2010-03-10

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2010-03-10